Literature DB >> 11878902

Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA.

A Cara1, J Vargas, M Keller, S Jones, A Mosoian, A Gurtman, A Cohen, V Parkas, F Wallach, E Chusid, I H Gelman, M E Klotman.   

Abstract

Closed circular (cc) forms of extrachromosomal HIV DNA are detected in patients with high viral loads; however, it is unclear whether these forms remain if virus replication is suppressed to undetectable levels by combination antiretroviral therapy. A nested primer polymerase chain reaction amplification assay was used to detect the presence of ccDNA containing two long terminal repeat sequences (2-LTR) in PBMC of patients with low or undetectable plasma HIV RNA. Fifty percent of patients with plasma RNA levels <50 copies/ml of blood had detectable 2-LTR DNA. Sequencing of the products identified normal LTR--LTR junctions in the minority of cases with the majority containing anomalies including deletions and insertions. The persistence of HIV ccDNA in patients with no detectable plasma RNA could be consistent with ongoing de novo infection of dividing cells or with stability of this form of DNA in nondividing cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878902     DOI: 10.1006/viro.2001.1243

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients.

Authors:  Roberta Bona; Silvia Baroncelli; Gabriella D'Ettorre; Mauro Andreotti; Giancarlo Ceccarelli; Piero Filati; Pasqualina Leone; Maria Blasi; Zuleika Michelini; Clementina Maria Galluzzo; Alessandra Mallano; Vincenzo Vullo; Andrea Cara
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-24       Impact factor: 2.205

2.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia.

Authors:  Jennifer L McDermott; Isabella Martini; Davide Ferrari; Francesca Bertolotti; Claudio Giacomazzi; Giuseppe Murdaca; Francesco Puppo; Francesco Indiveri; Oliviero E Varnier
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Persistent transcription of a nonintegrating mutant of simian immunodeficiency virus in rhesus macrophages.

Authors:  Yanfang Zheng; Ilnour Ourmanov; Vanessa M Hirsch
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

5.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

6.  Renal epithelial cells produce and spread HIV-1 via T-cell contact.

Authors:  Maria Blasi; Bala Balakumaran; Ping Chen; Donatella R M Negri; Andrea Cara; Benjamin K Chen; Mary E Klotman
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

Review 7.  Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

Authors:  Guido van Marle; Christopher Power
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

8.  IFN-ε protects primary macrophages against HIV infection.

Authors:  Carley Tasker; Selvakumar Subbian; Pan Gao; Jennifer Couret; Carly Levine; Saleena Ghanny; Patricia Soteropoulos; Xilin Zhao; Nathaniel Landau; Wuyuan Lu; Theresa L Chang
Journal:  JCI Insight       Date:  2016-12-08

9.  Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species.

Authors:  Audrey Brussel; Pierre Sonigo
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Disease Progression in HIV-1-Infected Viremic Controllers.

Authors:  Katherine C Groves; David F Bibby; Duncan A Clark; Are Isaksen; Jane R Deayton; Jane Anderson; Chloe Orkin; Andrew J Stagg; Aine McKnight
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.